Strophanthidin (Compound)

Synonyms:strophanthidin, Strophanthidine, Convallatoxigenin, 66-28-4, Corchsularin, k-Strophanthidin, Corchorgenin, Corchorin, Erysimupicrone, Corchoside A aglycon, Strophanthidin K, Erysimupikron, Apocynamarin, Cymarigenin, k-Strophanthidine, Apocymarin, Cynotoxin, 5beta-Hydroxy-19-oxodigitoxigenin, NSC-86078, 3beta,5,14-Trihydroxy-19-oxo-5beta-card-20(22)-enolide, CHEBI:38178, NSC86078, Antibiotic XS-89, MLS002153969, (3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde, W5O632DN33, XS-89, Strophantidine, Cyanotoxin, (3.beta.,5.beta.)-3,5,14-Trihydroxy-19-oxocard-20(22)-enolide, 5-beta-Hydroxy-19-oxodigitoxigenin, EINECS 200-626-6, NSC 86078, 3beta,5,14-Trihydroxy-19-oxo-5beta,20(22)-cardenolide, BRN 0097859, Strophantidin, UNII-W5O632DN33, 5.beta.-Hydroxy-19-oxodigitoxigenin, Prestwick_117, kappa-Strophanthidine, MFCD00046266, STROPHANTHIN-K, Corchoside A, aglycon, 3-beta,5,14-Trioxy-19-oxo-carden-(20:22)-olid [German], 3-beta,5,14-Trioxy-19-oxo-digen-(20:22)-olid [German], (3beta,5beta)-3,5,14-Trihydroxy-19-oxocard-20(22)-enolide, 19-Oxo-cardogenen-(20:22)-triol-(3-beta,5,14) [German], 3-beta,5,14-Trihydroxy-19-oxo-5-beta-card-20(22)-enolide, Prestwick0_000710, Prestwick1_000710, Prestwick2_000710, Prestwick3_000710, Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3beta,5beta)-, STROPHANTHIDIN [MI], BSPBio_000899, 5-18-05-00126 (Beilstein Handbook Reference), SCHEMBL240582, 3-beta,5,14-Trioxy-19-oxo-carden-(20:22)-olid, 3-beta,5,14-Trioxy-19-oxo-digen-(20:22)-olid, SPBio_002820, 5.beta.-Card-20(22)-enolide, 3.beta.,5,14-trihydroxy-19-oxo-, BPBio1_000989, CHEMBL111743, STROPHANTHIN-K [WHO-DD], 19-OXO-CARDOGENEN-(20:22)-TRIOL-(3-beta,5,14), DTXSID00903966, 5beta-Card-20(22)-enolide, 3beta,5,14-trihydroxy-19-oxo-, HMS1570M21, HMS2097M21, HMS2233O14, 5-beta-CARD-20(22)-ENOLIDE, 3-beta,5,14-TRIHYDROXY-19-OXO-, BDBM50255120, LMST01120005, AKOS024280415, Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3-beta,5-beta)-, NCGC00142399-02, (1S,2S,5S,7S,11S,10R,14R,15R)-5,7,11-trihydroxy-15-methyl-14-(5-oxo(3-2-hydrof uryl))tetracyclo[8.7.0.0<2,7>.0<11,15>]heptadecane-2-carbaldehyde, NCI60_041903, SMR001233308, HY-114252, CS-0080731, C19988, F82324, SR-01000838893, Q1718068, SR-01000838893-2, BRD-K84595254-001-03-0, BRD-K84595254-001-10-5, 5.beta.-Card-20(22)-enolide,5,14-trihydroxy-19-oxo-, WLN: L E5 B666TJ AVH E1 IQ MQ OQ F- DT5OV EHJ, 3.beta.,14-Trihydroxy-19-oxo-5.beta.-card-20(22)-enolide, CARD-20(22)-ENOLIDE, 3,5,14-TRIHYDROXY-19-OXO-, Card-20(22)-enolide,5,14-trihydroxy-19-oxo-, (3.beta.,5.beta.)-

Pubchem:PUBCHEM:6185

Id:f069a473-bd4e-5916-994f-6c0d22df5587

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Strophanthidin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Strophanthidin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Strophanthidin.

Results found

Linked to

	Label	Description
	BRD-K84595254-001-10-5 Substance (Entity type)	A Substance
	strophanthidin (5d2d7a4d-d5fb-4e04-948b-4074eacbf18a) Collection (Entity type)	Metadatata for strophanthidin
	helveticoside in similarity relationship with Strophanthidin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin positively regulates TSC22D2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin positively regulates GADD45B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID103904634 in similarity relationship with Strophanthidin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin negatively regulates DNAJB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin positively regulates ALCAM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin negatively regulates NQO2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Strophanthidin negatively regulates ASNS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS